TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VRDN

Viridian Therapeutics Inc

Healthcare · Biotechnology

20.70$ -3.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Viridian Therapeutics Inc (VRDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,097 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VRDN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
329 490 630 586 772 742 661 582 577 899 789 1,097
324 486 627 582 767 738 657 579 572 894 785 1,081
112 103 92 108 200 100 116 117 170 212 176 165
313 477 613 571 753 718 637 563 491 875 762 982
0.1 0.1 0.1 – 0.0 – – – 70 – – 75
– – 0.0 – – – – – – – – –
– – – – – – – – – – – 10
45 48 48 56 64 71 57 67 74 177 153 435
23 27 26 37 41 48 34 53 51 71 52 64
0.8 0.8 0.3 3.5 0.6 0.5 0.5 9.0 0.7 0.8 0.7 0.7
3.7 2.2 2.7 3.1 6.3 2.1 3.9 8.5 10 8.7 13 8.7
20 20 20 17 21 21 21 12 21 50 50 242
284 442 583 529 707 672 604 515 503 722 636 662
-659 -726 -774 -839 -916 -996 -1,083 -1,184 -1,218 -1,338 -1,443 -1,570
44 50 61 64 66 80 81 82 82 85 102 108

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?